MeSH tree: D09.408
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic effects of anthracyclines, ...
Feb 4, 2025
0
22
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was compared to usual treatment ...
Jan 31, 2025
0
17
Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine vial.
Jan 30, 2025
0
85
Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell metabolism. Their analysis also led to the discovery of previously unknown mechanisms for known medications. ...
Jan 28, 2025
0
44
Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is because the primary tumor continuously releases cancer cells into the blood. These circulating tumor cells ...
Jan 24, 2025
0
58
When an 84-year-old man in Hong Kong went to hospital with an enlarged prostate, doctors were startled to see that his skin—and even the whites of his eyes—had turned silver-gray. A deeper investigation revealed silver deposits ...
Jan 20, 2025
0
34
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.
Jan 6, 2025
0
21
Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy damages heart cells—and they have identified a drug that could keep the heart cells beating.
Nov 29, 2024
0
28
Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated ...
Nov 18, 2024
0
22
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients' age.
Oct 25, 2024
0
19
